Sigma Planning Corp’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,569
Closed -$218K 1214
2024
Q1
$218K Buy
+1,569
New +$197K 0.01% 1104
2022
Q2
Sell
-1,564
Closed -$200K 1328
2022
Q1
$200K Buy
1,564
+48
+3% +$5.25K 0.01% 1263
2021
Q4
$204K Sell
1,516
-400
-21% -$57.5K 0.01% 1271
2021
Q3
$262K Hold
1,916
0.01% 1134
2021
Q2
$205K Sell
1,916
-548
-22% -$52.6K 0.01% 1286
2021
Q1
$221K Buy
2,464
+180
+8% +$16.9K 0.01% 1149
2020
Q4
$211K Sell
2,284
-592
-21% -$52.9K 0.01% 1078
2020
Q3
$296K Sell
2,876
-256
-8% -$26.7K 0.01% 799
2020
Q2
$318K Buy
+3,132
New +$280K 0.01% 760
2019
Q4
Sell
-5,824
Closed -$217K 1063
2019
Q3
$217K Buy
+5,824
New +$226K 0.01% 888

Other funds holding DXCM

Sigma Planning Corp's DXCM Position: Q2 2024 in Review

Sigma Planning Corp sold out of DexCom (DXCM) in Q2 2024, closing a stake of 1,569 shares — an estimated $218K sold.

Sigma Planning Corp first reported a position in DXCM in Q3 2019 and held it in 10 quarters. The position peaked at $318K in Q2 2020. 1,000 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Sigma Planning Corp reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Sigma Planning Corp sold 1,569 DexCom shares in Q2 2024, an estimated $218K.
  • Sigma Planning Corp first reported a position in DexCom in Q3 2019 and held it in 10 quarters.
  • Sigma Planning Corp's DexCom position peaked at $318K in Q2 2020.
  • 1,000 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Sigma Planning Corp's 13F filing for Q2 2024, filed 6 Aug 2024.